Petra S van den Pangaart
Overview
Explore the profile of Petra S van den Pangaart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veer C, van den Pangaart P, Kruijswijk D, Florquin S, de Vos A, van der Poll T
J Biol Chem
. 2011 Jun;
286(42):36603-18.
PMID: 21690093
In a mouse model of Escherichia coli sepsis characterized by a primary peritoneal infection with 10(4) E. coli and a gradually growing bacterial load, we here show that the early...
2.
de Vos A, Pater J, van den Pangaart P, de Kruif M, Veer C, van der Poll T
J Immunol
. 2009 Jun;
183(1):533-42.
PMID: 19542464
In vitro and in vivo experiments in mice have shown that exposure of cells to the TLR4 ligand LPS induces tolerance toward a second exposure to LPS and induces cross-tolerance...
3.
Leendertse M, Willems R, Giebelen I, Florquin S, van den Pangaart P, Bonten M, et al.
Intensive Care Med
. 2009 Feb;
35(5):924-32.
PMID: 19221713
Purpose: Multiresistant and vancomycin resistant Enterococcus faecium (VRE) can cause serious infections in hospitalized patients with various co-morbid diseases. We investigated the course of VRE peritonitis after cecal ligation and...
4.
Leendertse M, Willems R, Giebelen I, van den Pangaart P, Bonten M, van der Poll T
Immunology
. 2009 Jan;
128(1 Suppl):e335-42.
PMID: 19175794
Enterococcus faecium is an emerging pathogen that causes infections in hospitalized patients with various co-morbid diseases. These underlying diseases are often associated with an acute-phase response that renders patients vulnerable...
5.
Wiersinga W, Vant Veer C, van den Pangaart P, Dondorp A, Day N, Peacock S, et al.
Crit Care Med
. 2008 Dec;
37(2):569-76.
PMID: 19114913
Objectives: Sepsis is associated with immunosuppression (characterized by a reduced capacity of circulating monocytes to release proinflammatory cytokines), which has been implicated in late mortality. Melioidosis, caused by the Gram-negative...
6.
Giebelen I, Le Moine A, van den Pangaart P, Sadis C, Goldman M, Florquin S, et al.
J Infect Dis
. 2008 Jul;
198(5):750-7.
PMID: 18627272
Background: The efferent vagus nerve can inhibit inflammation via interaction between acetylcholine and alpha7 cholinergic receptors. Methods: To determine the role played by alpha7 receptors in antibacterial defense, peritonitis was...
7.
Leendertse M, Willems R, Giebelen I, van den Pangaart P, Wiersinga W, de Vos A, et al.
J Immunol
. 2008 Mar;
180(7):4865-74.
PMID: 18354210
The incidence of infections with Enterococcus faecium is increasing worldwide. TLRs have been implicated in the recognition of pathogens and the initiation of an adequate innate immune response. We here...
8.
Veer C, van den Pangaart P, van Zoelen M, de Kruif M, Birjmohun R, Stroes E, et al.
J Immunol
. 2007 Nov;
179(10):7110-20.
PMID: 17982103
Recent in vitro and murine in vivo studies have identified several potential LPS tolerance factors. In this study, we describe the expression kinetics of these LPS tolerance factors in standardized...
9.
de Kruif M, Lemaire L, Giebelen I, Groot A, Pater J, van den Pangaart P, et al.
Shock
. 2007 Oct;
29(4):458-61.
PMID: 17909456
Corticosteroids are widely used for the suppression of cell-mediated cytoxicity. This process is mediated by natural killer cells and cytotoxic T lymphocytes, and their activation can be monitored by levels...
10.
Sanders N, Eijsink V, van den Pangaart P, van Neerven R, Simons P, De Smedt S, et al.
Biochim Biophys Acta
. 2007 Feb;
1770(5):839-46.
PMID: 17321686
Several pulmonary pathologies, like cystic fibrosis (CF), are characterized by hypersecretion and stasis of tenacious mucus. Bacterial glycosidases are known to degrade mucins but their use as mucolytic agents is...